Download PDF
Hamostaseologie 1984; 04(04): 134-137
DOI: 10.1055/s-0038-1659937
Originaler Artikel
Schattauer GmbH

Hämorrhagische Diathese bei chronischer Urämie

A. Benigni
1   »Mario Negri« Institut für Pharmakologische Forschung, Bergamo, Italien
,
G. Remuzzi
1   »Mario Negri« Institut für Pharmakologische Forschung, Bergamo, Italien
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Rabiner S. F.: Uremic bleeding. In: Progress in Hemostasis and Thrombosis. Spaet T.H. (Ed.) Grüne & Stratton; New York: 1972: 233.
    Google Scholar
  • 2 Remuzzi G, Schieppati A, Mecca G. Abnormal platelet function in haemodialy-sed patients: current concepts. Int. J. Artif. Org. 2: 109-112 1979;
    PubMedGoogle Scholar
  • 3 Castaldi P.A, Rosenberg M.C, Stewart J.H. The bleeding disorder of uremia: a qualitative platelet defect. Lancet II: 66-69 1966;
    PubMedGoogle Scholar
  • 4 Rabiner S.E, Molinas F. The role of phenol and phenolic acid on the thrombocy-topathy and defective platelet aggregation of patients with renal failure. Amer. J. Med. 49: 346-351 1970;
    CrossrefPubMedGoogle Scholar
  • 5 Lindsay R.M, Friesen M, Koens F, Linton A.L, Oreopoulos D, De Veber G. Platelet function in patients on long term peritoneal dialysis. Clin. Nephrol. 6: 335-339 1976;
    PubMedGoogle Scholar
  • 6 Horowitz H.L, Stein I.M, Cohen B.D, White J.G. Further studies on the platelet inhibiting effect of guanidinosuccinic acid and its role in uremic bleeding. Amer. J. Med. 49: 336 1970;
    CrossrefPubMedGoogle Scholar
  • 7 Eknoyan G, Wacksman S.J, Glueck H.J, Will J.J. Platelet function in renal failure. New Engl. J. Med. 280: 677-681 1969;
    CrossrefPubMedGoogle Scholar
  • 8 Salzman E.W, Neri L.L. Adhesiveness of blood platelets in uremia. Thromb. Diath. Haemorrh. 75: 89-92 1966;
    PubMedGoogle Scholar
  • 9 Rabiner S.F, Hrodek O. Platelet factor 3 in normal subjects and patients with renal failure. J. Clin. Invest. 47: 901 1968;
    CrossrefPubMedGoogle Scholar
  • 10 Steiner R.W, Coggins C, Carvalho C.A. Bleeding time in uremia: a useful test to assess clinical bleeding. Amer. J. Haematol. 7: 107-117 1979;
    PubMedGoogle Scholar
  • 11 Horowitz H.I. Uremic toxins and platelet function. Archs. Intern. Med. 126: 823-826 1970;
    CrossrefPubMedGoogle Scholar
  • 12 Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G. Bleeding in renal failure. Altered platelet function in chronic uremia only partly corrected by haemodia-lysis. Nephron 22: 347-353 1978;
    CrossrefPubMedGoogle Scholar
  • 13 Sakariassen K.S, Bolhuis P.A, Sixma J.J. Human blood platelet adhesion to artery subendothelium is mediated by factor VHI-von Willebrand factor bound to the subendothelium. Nature 279: 636-638 1979;
    CrossrefPubMedGoogle Scholar
  • 14 Born G.V.R, Bergquist D, Arfors K.E. Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes. Nature 259: 233-235 1976;
    CrossrefPubMedGoogle Scholar
  • 15 Turitto V.T, Weiss H.I. Red blood cells: their dual role in thrombus formation. Science 207: 541-543 1980;
    CrossrefPubMedGoogle Scholar
  • 16 Livio M, Marchesi D, Remuzzi G, Gotti E, Mecca G, de Gaetano G. Uremie bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet II: 1013-1015 1982;
    PubMedGoogle Scholar
  • 17 Remuzzi G, Bertani T, Mecca G, Donati M.B, de Gaetano G. Factor VlII-related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times. Brit. Med. J. 1: 70-72 1978;
    CrossrefPubMedGoogle Scholar
  • 18 Herrmann R.P, Marshall L.R, Hurst P.E. Bleeding in renal failure: a possible cause. Brit. Med. J. 1: 1601-1602 1977;
    PubMedGoogle Scholar
  • 19 Ekberg M.R, Nilsson I.M, Linell F. Significance of increased factor VIII in early glomerulonephritis. Ann. Intern. Med. 83: 337-341 1975;
    CrossrefPubMedGoogle Scholar
  • 20 Kazatchkine M, Sultan Y, Caen J.P, Bariety J. Bleeding in uremia: a possible cause. Brit. Med. J. 2: 612-615 1976;
    CrossrefPubMedGoogle Scholar
  • 21 Warrell Jr. R.P, Hultin M.B, Coller B.S. Increased factor VIII/von Wille-brand factor antigen and von Willebrand factor activity in renal failure. Amer. J. Med. 66: 226-228 1979;
    CrossrefPubMedGoogle Scholar
  • 22 Howard H.A, Whitworth J.A, Hendrix L.E, Thomas K.B, Firkin B.G. Abnormal factor VIII in chronic renal failure. Med. J. Aust. 1: 148-151 1979;
    PubMedGoogle Scholar
  • 23 Remuzzi G, Livio M, Roncaglioni M.C, Mecca G, Donati M.B, de Gaetano G. Bleeding in renal failure: is von Willebrand factor implicated?. Brit. Med. J. 2: 359-361 1979;
    PubMedGoogle Scholar
  • 24 Warell Jr. R.P, Hultin M.B, Coller B.S. Increased factor VIII/von Wille-brand factor antigen and von Willebrand factor activity in renal failure. Amer. J. Med. 66: 226-228 1979;
    CrossrefPubMedGoogle Scholar
  • 25 Herrmann R.P, Marshall L.R, Hurst P.E. Bleeding in renal failure: a possible cause. Brit. Med. J. 1: 1601-1602 1977;
    PubMedGoogle Scholar
  • 26 Ruggeri Z.M, Ponticelli C, Mannucci P.M. Factor VIII and chronic renal failure. Brit. Med. J. 1: 1085 1977;
    PubMedGoogle Scholar
  • 27 Deykin D. Uremic bleeding. Kidney Int. 24: 698-705 1983;
    CrossrefPubMedGoogle Scholar
  • 28 Holmsen H, Day H.J, Setkowsky C.A. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenalin. Biochem. J. 129: 67-82 1972;
    CrossrefPubMedGoogle Scholar
  • 29 Karpatkin S, Langer R.M. Biochemical energetic of simulated platelet plug formation. Effect of thrombin, adenine diphosphate and epinephrine on intra- and extracellular adenine nucleotide kinetics. J. Clin. Invest. 47: 2158-2168 1968;
    CrossrefPubMedGoogle Scholar
  • 30 Holmsen H. The platelet. Its membrane, physiology and biochemistry. Clin. Haematol. 1: 235-266 1972;
    PubMedGoogle Scholar
  • 31 Deykin D. Emerging concepts of platelet function. New Engl. J. Med. 290: 144-145 1974;
    CrossrefPubMedGoogle Scholar
  • 32 Eknoyan G, Brown C.H. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Amer. J. Nephrol. 1: 17-23 1981;
    CrossrefPubMedGoogle Scholar
  • 33 Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, Poletti E, Mecca G, de Gaetano G. Parathyroid hormone inhibits human platelet function. Lancet II: 1321-1323 1981;
    PubMedGoogle Scholar
  • 34 Massry S.G, Goldstein D.A. The search for uremic toxin(s) “x”.: PTH. Clin. Nephrol. 11: 181-189 1979;
    PubMedGoogle Scholar
  • 35 Leithner C, Sinzinger H, Kovarik J, Woloszczuk W. Parathyroid hormone does not inhibit platelet aggregation. Lancet I: 367-368 1984;
    PubMedGoogle Scholar
  • 36 Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, de Gaetano G, Day J.S, Smith W.L, Pinca E, Patrignani P, Patrono C. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect. J. Clin. Invest. 71: 762-768 1983;
    CrossrefPubMedGoogle Scholar
  • 37 Patrono C, Ciabattoni G, Pinea E, Pugliese F, Castrucci G, de Salvo A, Satta M.A, Peskar B.A. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb. Res. 17: 317-327 1980;
    CrossrefPubMedGoogle Scholar
  • 38 Moneada S, Gryglewsky R, Bunting S, Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (London) 263: 663-665 1976;
    CrossrefPubMedGoogle Scholar
  • 39 Leithner C, Winter M, Silberbauer K, Wagner O, Pinggera W, Sinzinger H. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats. In: Dialysis Transplantation Nephrology. Robinson B.H.B, Hawkins J.B. (eds.) Kent; Pitman Medical, Tunbridge Wells: 1978: 418-422.
    Google Scholar
  • 40 Defreyn G, Vergara Dauden M, Machin S.J, Vermylen J. A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells. Thromb. Res. (in Press).
    PubMedGoogle Scholar
  • 41 Janson P.A, Jubelirer S.J, Weinstein M.S, Deykin D. Treatment of bleeding tendency in uremia with cryoprecipitate. New Engl. J. Med. 303: 1318-1322 1980;
    CrossrefPubMedGoogle Scholar
  • 42 Prowse C.V, Sas G, Gader A.M.A, Cort J.H, Cash J.D. Specificity in the factor VIII response to vasopressin infusion in man. Brit. J. Haematol. 41: 437-447 1979;
    CrossrefPubMedGoogle Scholar
  • 43 Ludlam C.A, Peake I.R, Allen N, Davies B.L, Furlong R.A, Bloom A.L. Factor VIII and fibrinolytic response to deamino-8-d-arginine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Wille-brand’s disease. Brit. J. Haematol. 45: 499-511 1980;
    CrossrefPubMedGoogle Scholar
  • 44 Nilsson I.M, Holmberg L, Aberg M, Vilhardt H. The release of plasminogen activator and factor VIII after injection of DDAVP in healthy volunteers and in patients with von Willebrand’s disease. Scand. J. Haematol. 24: 351-359 1980;
    PubMedGoogle Scholar
  • 45 Mannucci P.M, Canciani M.T, Rota L, Donovan B.S. Response of factor VIII/ von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand’s disease. Brit. J. Haematol. 47: 283-293 1981;
    CrossrefPubMedGoogle Scholar
  • 46 Mannucci P.M, Ruggeri Z.M, Pareti F.I, Capitanio A. 1-deamino-8-d-argini-ne vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand’s disease. Lancet I: 869-872 1977;
    PubMedGoogle Scholar
  • 47 Theiss W, Sauer E. DDAVP: Alternative zur Substitutionsbehandlung bei leichter Hämophilie A und Von-Willebrand-Jür-gens-Syndrom. Dtsch. Med. Wschr. 102: 1769-1772 1977;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Ingram G.I.C, Hilton P.J. DDAVP in haemophilia. Lancet II: 721-722 1977;
    PubMedGoogle Scholar
  • 49 Ockelford P.A, Menon N.C, Berry E.W. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand’s disease and mild haemophilia. N. Z. med. J. 92: 375-378 1980;
    PubMedGoogle Scholar
  • 50 Dewald D.L, Briggs B, Smith R.E. Intranasal administration of desmopressin acetate (DDAVP) to hemophiliacs. Thromb. Res. 18: 617-622 1980;
    CrossrefPubMedGoogle Scholar
  • 51 Mannucci P.M, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmermann T.S. Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. New Engl. J. Med. 308: 8-12 1983;
    CrossrefPubMedGoogle Scholar